Understanding the chemical profile of pharmaceutical intermediates is vital for innovation in drug development. NINGBO INNO PHARMCHEM CO.,LTD. offers Abiraterone Acetate Powder (CAS 154229-18-2), a compound with a defined chemical structure (C26H33NO2) and molecular weight (391.55), which is crucial for its function. Our focus on 'pharmaceutical intermediate prostate cancer' ensures that we provide materials that meet precise scientific requirements.

The term 'abiraterone acetate powder purity' is not merely a technical specification but a guarantee of quality and consistency. NINGBO INNO PHARMCHEM CO.,LTD. ensures that our product meets a minimum purity of 99%, a standard that is essential for its application as an Active Pharmaceutical Ingredient (API) precursor. This high level of purity is particularly important when seeking a 'high purity abiraterone acetate supplier' for sensitive medical applications.

As a key 'treatment for metastatic prostate cancer intermediate', Abiraterone Acetate plays a significant role in endocrine therapy. Its precise chemical properties allow it to inhibit CYP17A1, an enzyme critical for androgen biosynthesis. For manufacturers looking to 'buy abiraterone acetate bulk', understanding these chemical functions and ensuring the 'CAS 154229-18-2 medicine grade' compliance is fundamental to the success of their research and production.

The manufacturing of Abiraterone Acetate powder involves complex synthesis pathways. NINGBO INNO PHARMCHEM CO.,LTD.'s expertise in chemical synthesis and purification allows us to consistently deliver a product that adheres to international pharmaceutical standards. Our role as a provider of 'pharmaceutical intermediate prostate cancer' materials reinforces our commitment to supporting advancements in medical treatment through high-quality chemical products.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supplying pharmaceutical-grade Abiraterone Acetate powder, providing the essential chemical foundation for critical medical treatments and further research in oncology.